• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

2012

Sales are flat, profits plunge in the 2nd quarter for Symmetry Medical

August 5, 2013 By Brad Perriello Leave a Comment

Sales are flat, profits plunge in the 2nd quarter for Symmetry Medical

Symmetry Medical (NYSE:SMA) saw its 2nd-quarter profits plunge more than 28% on flat sales and lowered its outlook for the balance of the year.

Filed Under: MassDevice Earnings Roundup, News Well Tagged With: 2012, Q2, Symmetry Medical Inc.

Biomet swings to Q4 black, pares fiscal 2013 losses

July 11, 2013 By Brad Perriello Leave a Comment

Biomet swings to Q4 black, pares fiscal 2013 losses

Biomet said it posted black ink during the 4th quarter and cut its losses for fiscal 2013, reporting a 1.0 % decline in large joint reconstruction sales.

The privately held medical device company, which is said to be considering an IPO or sale, is closely watched as a bellwether for the orthopedic market, which has been bedeviled in recent years by falling procedure volumes for hip and knee replacements.

Filed Under: MassDevice Earnings Roundup, News Well, Orthopedics Tagged With: 2012, Biomet, Q2

EDAP’s losses widen, sales increase in 2012

June 3, 2013 By Sony Salzman Leave a Comment

Edap TMS

EDAP (NSDQ:EDAP) posted a slight bump in sales but a dramatic increase in losses for the fiscal year of 2012

The French device maker posted year-end losses of $9.7 million, or 55¢ per diluted share, on sales of $33.7 million. That compares with 2011 losses of $1.3 million, or 10¢ per diluted share, on sales of $31.2 million.

Filed Under: MassDevice Earnings Roundup, News Well Tagged With: 2012, EDAP TMS SA, Q4

FDA accepts Edap’s Ablatherm PMA application

April 10, 2013 By Sony Salzman Leave a Comment

Edap TMS

Edap (NSDQ:EDAP) said the FDA accepted its pre-market approval application for its Ablatherm ultrasound prostate cancer treatment, backed by data from its Enlight investigational device exemption study.

The Vaulx-en-Velin, France-based medical device company also reported that its losses increased by a whopping 646% during the 2012, on an 8% sales increase.

Filed Under: MassDevice Earnings Roundup, News Well, Oncology, Pre-Market Approval (PMA), Ultrasound Tagged With: 2012, EDAP TMS SA, Q4

FDA approves 1st Type 2 diabetes drug | Wall Street Beat

April 1, 2013 By Brad Perriello Leave a Comment

MassDevice.com Wall Street Beat

The FDA approved a 1st-of-its-kind treatment for Type 2 diabetes, Johnson & Johnson‘s (NYSE:JNJ) Invokana, with the federal watchdog agency citing it as a pioneer in a new class of diabetes drug.

Filed Under: Funding Roundup, MassDevice Earnings Roundup, News Well, Pharmaceutical, Wall Street Beat Tagged With: 2012, Covidien, Hansen Medical Inc., Johnson and Johnson, PLC Systems Inc., Q4, TriReme Medical Inc.

Sanuwave slashes workforce by 65%, but pares losses by more than a third

April 1, 2013 By Sony Salzman Leave a Comment

Sanuwave logo

Sanuwave Health (OTC:SNWV) laid off more than ⅓ of its workforce in its quest to pare its 2012 losses, according to a regulatory filing, shrinking from 28 employees to 10.

Filed Under: MassDevice Earnings Roundup, News Well, Orthopedics, Ultrasound Tagged With: 2012, Layoffs, Q4, SANUWAVE Health Inc., Securities & Exchange Commission (SEC)

Kips Bay rises on FDA trial approval, despite losses in sales and revenue

March 29, 2013 By Arezu Sarvestani Leave a Comment

Kips Bay logo

Medical device maker Kips Bay Medical (NSDQ:KIPS) saw widening losses and sinking sales during its most recent quarter, but the company marked an important win with FDA approval to complete full enrollment in the U.S. arm of a feasibility study.

Filed Under: Food & Drug Administration (FDA), MassDevice Earnings Roundup, News Well, Stent Grafts, Wall Street Beat Tagged With: 2012, Clinical Trials, Kips Bay Medical Inc., Q4

AtriCure slips on missed Q4, 2012 results

March 5, 2013 By Brad Perriello Leave a Comment

AtriCure

AtriCure (NSDQ:ATRC) reported wider losses for 2012 and missed Wall Street’s expectations with its Q4 and full-year results, sending shares down on The Street last week.

The West Chester, Ohio-based medical device company posted losses of $2.0 million, or 12¢ per share, on sales of $18.4 million for the 3 months ended Dec. 31, 2012, for top-line growth of 9.6% and a loss reduction of 2.9%.

Filed Under: MassDevice Earnings Roundup, News Well Tagged With: 2012, AtriCure Inc., Cardiac Rhythm Management, Q4

Diabetes: Insulet gains on strong Q4, lands FDA win

March 5, 2013 By Arezu Sarvestani Leave a Comment

Insulet logo

Medical device maker Insulet (NSDQ:PODD) got a boost from Wall Street last week after releasing its 4th quarter and full-year 2012 financial report.

The news sent PODD shares up 5.5% in a single day on Feb. 28 after the company hosted its earnings call with investors.

Filed Under: Food & Drug Administration (FDA), MassDevice Earnings Roundup, News Well, Regulatory/Compliance, Wall Street Beat Tagged With: 2012, Insulet, Q4

Hansen Medical’s Q4 profits rise on patent deal, but 2012 losses still widen

March 4, 2013 By Brad Perriello Leave a Comment

Hansen Medical

Hansen Medical (NSDQ:HNSN) managed to eke out a profit during the 4th quarter on the sale and licensing of some of its patents, but still posted wider losses for 2012, sending shares down on Wall Street last week.

Filed Under: MassDevice Earnings Roundup, News Well, Robotics Tagged With: 2012, Hansen Medical Inc., Q4

UPDATE: NxStage Medical CEO on its Wall-Street-beating Q4 results

February 28, 2013 By MassDevice staff Leave a Comment

NxStage  press release

NxStage Medical (NSDQ:NXTM) shares jumped nearly 8% today after the medical device company reported Wall-Street-beating results for the 4th quarter and 2012.

Filed Under: MassDevice Earnings Roundup, News Well Tagged With: 2012, Dialysis, NxStage Medical Inc., Q4

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 17
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS